In search of definitions: Cancer‐associated fibroblasts and their markers
Top Cited Papers
Open Access
- 7 February 2019
- journal article
- review article
- Published by Wiley in International Journal of Cancer
- Vol. 146 (4) , 895-905
Abstract
The tumor microenvironment has been identified as one of the driving factors of tumor progression and invasion. Inside this microenvironment, cancer‐associated fibroblasts (CAFs), a type of perpetually activated fibroblasts, have been implicated to have a strong tumor‐modulating effect and play a key role in areas such as drug resistance. Identification of CAFs has typically been carried based on the expression of various “CAF markers”, such as fibroblast activation protein alpha (FAP) and alpha smooth muscle actin (αSMA), which separates them from the larger pool of fibroblasts present in the body. However, as outlined in this Review, the expression of various commonly used fibroblast markers is extremely heterogeneous and varies strongly between different CAF subpopulations. As such, novel selection methods based on cellular function, as well as further characterizing research, are vital for the standardization of CAF identification in order to improve the cross‐applicability of different research studies in the field. The aim of this review is to give a thorough overview of the commonly used fibroblast markers in the field and their various strengths and, more importantly, their weaknesses, as well as to highlight potential future avenues for CAF identification and targeting.Keywords
Funding Information
- Fonds National de la Recherche Luxembourg (C16/BM/11282028, R‐AGR‐3144‐12‐Z)
This publication has 109 references indexed in Scilit:
- Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis InitiationCancer Cell, 2012
- Podoplanin‐expressing inflammatory macrophages activate murine platelets via CLEC‐2Journal of Thrombosis and Haemostasis, 2012
- Rationale Behind Targeting Fibroblast Activation Protein–Expressing Carcinoma-Associated Fibroblasts as a Novel Chemotherapeutic StrategyMolecular Cancer Therapeutics, 2012
- Tumor-produced, active Interleukin-1 β regulates gene expression in carcinoma-associated fibroblastsExperimental Cell Research, 2011
- Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancerProceedings of the National Academy of Sciences, 2011
- Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liverProceedings of the National Academy of Sciences, 2010
- Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblastsProceedings of the National Academy of Sciences, 2010
- Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal FibroblastsMolecular Cancer, 2010
- Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent MannerCancer Cell, 2010
- CD90 Expression on human primary cells and elimination of contaminating fibroblasts from cell culturesCytotechnology, 2009